In this issue:
PSMA PET-CT + mpMRI for diagnosis of prostate cancer
PSMA PET-CT patterns optimise prostate cancer diagnosis
Systemic treatments for mCSPC
Prostate cancer screening with MRI or ultrasonography
PSA testing changes after USPSTF recommendations
Clinical and pre-clinical approaches to diagnosis and risk stratification
Prostate zones and cancer
2022 cancer statistics
Definitive radiotherapy for localised prostate cancer in Black and White men
Acceptance and efficacy of recommended adjuvant radiotherapy
Please login below to download this issue (PDF)